Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease.
Phase of Trial: Phase IV
Latest Information Update: 29 May 2018
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 16 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2013 Planned end date (1 Oct 2013) added as reported by ClinicalTrials.gov.
- 18 Sep 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.